Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMO | O15229 | 1/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.44 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TDO2 | P48775 | 1/20 | 0.40 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6100303 | 1.00 | KMO (0.53) | KMOHDAC4HDAC2HDAC8BACE1 | |
| SCHEMBL16334825 | 0.98 | HDAC4 (0.52) | KMOHDAC4HDAC2HDAC8BACE1 | |
| Hydrochloric Acid SCHEMBL4444055 | 0.96 | HDAC4 (0.50) | KMOHDAC4HDAC2HDAC8BACE1 | |
| SCHEMBL18956824 | 0.94 | HDAC4 (0.47) | KMOHDAC4HDAC2HDAC8BACE1 | |
| SCHEMBL273350 | 0.89 | CYP3A4 (0.50) | KMOHDAC4HDAC2HDAC8CYP3A4 | |
| SCHEMBL29411064 | 0.89 | CYP3A4 (0.50) | KMOHDAC4HDAC2HDAC8CYP3A4 | |
| Hydrochloric Acid SCHEMBL25305777 | 0.87 | CYP3A4 (0.48) | KMOHDAC4HDAC2HDAC8CYP3A4 | |
| SCHEMBL5667650 | 0.87 | KMO (0.64) | KMOHDAC4HDAC2HDAC8BACE1 | |
| SCHEMBL669730 | 0.87 | KMO (0.64) | KMOHDAC4HDAC2HDAC8BACE1 | |
| SCHEMBL5666805 | 0.84 | KMO (0.62) | KMOHDAC4HDAC2HDAC8BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120192449-A | Maleimide high heat-resistant impact modifier and preparation method thereof | 浙江烯苯醇新材料科技有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-114917727-B | Hydrophobic eutectic solvent and preparation method and application thereof | 苏州中科地星创新技术研究所有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-114917727-A | Hydrophobic eutectic solvent and preparation method and application thereof | 苏州中科地星创新技术研究所有限公司 | 2022-08-19 | — | — | CN | claimed |
| US-9690218-B2 | Intermediate transfer member | XEROX CORPORATION (US) | 2017-06-27 | — | — | US | claimed |
| EP-2290452-B1 | POSS melamine overcoated photoconductors | XEROX CORP (US) | 2016-06-01 | — | — | EP | claimed |
| US-8435632-B2 | Intermediate transfer member | XEROX CORPORATION (US) | 2013-05-07 | — | — | US | claimed |
| US-8283398-B2 | Polyhedral silsesquioxane modified polyimide containing intermediate transfer members | XEROX CORPORATION (US) | 2012-10-09 | — | — | US | claimed |
| US-20110223436-A1 | INTERMEDIATE TRANSFER MEMBER | XEROX CORPORATION (US) | 2011-09-15 | — | — | US | claimed |
| US-20110223404-A1 | INTERMEDIATE TRANSFER MEMBER | XEROX CORPORATION (US) | 2011-09-15 | — | — | US | claimed |
| US-20110053066-A1 | POSS MELAMINE OVERCOATED PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2011-03-03 | — | — | US | claimed |
| US-7897314-B1 | Poss melamine overcoated photoconductors | XEROX CORPORATION (US) | 2011-03-01 | — | — | US | claimed |
| US-20110027598-A1 | POLYHEDRAL SILSESQUIOXANE MODIFIED POLYIMIDE CONTAINING INTERMEDIATE TRANSFER MEMBERS | XEROX CORPORATION (US) | 2011-02-03 | — | — | US | claimed |
| CN-117428187-B | Method for preparing carbon-coated copper by in-situ reduction of polydopamine-like copper oxide, carbon-coated copper and application | 深圳大学 | 2026-05-19 | — | — | CN | disclosed |
| EP-4722319-A2 | COMPOSITION WITH ORGANIC MOLECULES | Samsung Display Co., Ltd. (KR) | 2026-04-08 | — | — | EP | disclosed |
| US-12595243-B2 | Modulators of extracellular signal-regulated kinase | GEN1E LIFESCIENCES INC. (US) | 2026-04-07 | — | — | US | disclosed |
| EP-4077337-B1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2026-03-18 | — | — | EP | disclosed |
| US-4725616-A | ANTIARTHRITIC AGENTS | PFIZER INC. (US) | 1988-02-16 | — | — | US | disclosed |
| EP-0208510-A2 | 1-Substituted oxindole-3-carboxamines as antiinflammatory and analgesic agents | PFIZER INC. (US) | 1987-01-14 | — | — | EP | disclosed |
| US-4616053-A | Hydrophobic polyamides | BAYER AKTIENGESELLSCHAFT (DE) | 1986-10-07 | — | — | US | disclosed |
| US-3960868-A | Derivatives of 6,7 or 8 cycloalkyl 4-oxo quinoline 3 carboxylic acid | CIBA-GEIGY CORPORATION (US) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595243-B2 | Modulators of extracellular signal-regulated kinase | CDC42BPG, GRK3, ERBB2 | KMO 3244/4885HDAC4 1861/4885HDAC2 1632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.